Provider Synergies provides Preferred Drug List (PDL) and Supplemental Rebate services for the Pennsylvania Department of Public Welfare's Medical Assistance (MA) Program. In this role, Provider Synergies negotiates and contracts Supplemental Rebate Agreements with pharmaceutical manufacturers, provides Pharmacy and Therapeutics (P&T) Committee support and clinical and financial review of drugs in PDL classes.
Pennsylvania is a participant in the TOP$ multistate pharmaceutical purchasing pool managed by Provider Synergies.
Pennsylvania Medicaid Preferred Drug List (PDL) effective January 20, 2016
Final PDL decisions for classes reviewed at the November 2015 P & T Committee meeting can be found here (PDF).
PDL changes will be implemented on January 20, 2016.
Pharmacy & Therapeutics Committee
The next meeting of the Pennsylvania DPW P&T Committee is tentatively scheduled for:
May 17, 2016 at 10:00am
Child Welfare Training Center
403 East Winding Hill Road
Mechanicsburg, PA 17055
The final agenda will be posted prior to the meeting.
More information on the Pennsylvania Department of Public Welfare Pharmacy and Therapeutics Committee is available at this page.
P&T Meeting Public Testimony Request Form
Participation in the Supplemental Rebate Process for Pennsylvania Medicaid
Each participating manufacturer is required to designate two individuals to serve as the points of contact between Provider Synergies and the manufacturer. These contacts are to be submitted to Provider Synergies on the Manufacturer Contact Form.
The Offer Form provides the mechanism for manufacturers to submit Supplemental Rebate offers for drugs being reviewed for the PDL program.
For questions about the PDL program, please e-mail PSPennsylvania@magellanhealth.com.